$245.00
An on-demand peptide injection that may help support sexual desire and arousal through brain pathways. Monthly supply.
Prescription treatments include a short medical intake at checkout. A licensed clinician reviews every order before anything is prescribed or shipped — if it is not approved, you are fully refunded.
PT-141 is a prescription medication and requires evaluation by a licensed clinician.
The FDA-approved version of bremelanotide (Vyleesi) is approved for hypoactive sexual desire disorder in premenopausal women. PT-141 is prescribed off-label for other patients and uses based on growing clinical experience.
This medication is compounded, meaning it's custom-prepared by a state-licensed pharmacy based on your clinician's prescription. Compounded PT-141 is not FDA-approved as a finished drug product.
PT-141 is not appropriate for patients with uncontrolled high blood pressure or cardiovascular disease. Your clinician will review your medical history, possible side effects, and whether this treatment is right for you.
Results vary and are not guaranteed.
Medications sourced from 503A and 503B U.S.-licensed pharmacies.
Lab testing conducted through CLIA-certified laboratories.
Care delivered by board-certified clinicians.
Available in all 50 states and Washington, D.C.